Removing Barriers to Allergy Diagnostic Testing Act of 2019

United States116th CongressHR-2009House of Representatives
Updated: Apr 2, 2019

Summary

Removing Barriers to Allergy Diagnostic Testing Act of 2019 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Introduced in House

  4. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.